UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Discovery of Nedd4 auto-ubiquitination inhibitors

Scientific reports, 2023-09, Vol.13 (1), p.16057-16057, Article 16057

2023

Volltextzugriff (PDF)

Identification and Structure–Activity Relationship of HDAC6 Zinc-Finger Ubiquitin Binding Domain Inhibitors

Journal of medicinal chemistry, 2018-05, Vol.61 (10), p.4517-4527

2018

Volltextzugriff (PDF)

Discovery and Characterization of a Highly Potent and Selective Aminopyrazoline-Based in Vivo Probe (BAY-598) for the Protein Lysine Methyltransferase SMYD2

Journal of medicinal chemistry, 2016-05, Vol.59 (10), p.4578-4600

2016

Volltextzugriff (PDF)

Discovery of a Potent and Selective Coactivator Associated Arginine Methyltransferase 1 (CARM1) Inhibitor by Virtual Screening

Journal of medicinal chemistry, 2016-07, Vol.59 (14), p.6838-6847

2016

Volltextzugriff (PDF)

CACHE (Critical Assessment of Computational Hit-finding Experiments): A public–private partnership benchmarking initiative to enable the development of computational methods for hit-finding

Nature reviews. Chemistry, 2022-04, Vol.6 (4), p.287-295

2022

Volltextzugriff (PDF)

The co-crystal structure of Cbl-b and a small-molecule inhibitor reveals the mechanism of Cbl-b inhibition

Communications biology, 2023-12, Vol.6 (1), p.1272-1272, Article 1272

2023

Volltextzugriff (PDF)

Development of selective class I protein arginine methyltransferase inhibitors through fragment-based drug design approach

European journal of medicinal chemistry, 2023-11, Vol.260, p.115713, Article 115713

2023

Volltextzugriff (PDF)

Discovery and Characterization of BAY-805, a Potent and Selective Inhibitor of Ubiquitin-Specific Protease USP21

Journal of medicinal chemistry, 2023-03, Vol.66 (5), p.3431-3447

2023

Volltextzugriff (PDF)

Development of LM-41 and AF-2112, two flufenamic acid-derived TEAD inhibitors obtained through the replacement of the trifluoromethyl group by aryl rings

Bioorganic & medicinal chemistry letters, 2023-10, Vol.95, p.129488-129488, Article 129488

2023

Volltextzugriff (PDF)

Kinetic Characterization of SARS-CoV‑2 nsp13 ATPase Activity and Discovery of Small-Molecule Inhibitors

ACS infectious diseases, 2022-08, Vol.8 (8), p.1533-1542

2022

Volltextzugriff (PDF)

Discovery of a First-in-Class Small-Molecule Ligand for WDR91 Using DNA-Encoded Chemical Library Selection Followed by Machine Learning

Journal of medicinal chemistry, 2023-12, Vol.66 (23), p.16051-16061

2023

Volltextzugriff (PDF)

Broad analgesic activity of a novel, selective M1 agonist

Neuropharmacology, 2017-09, Vol.123, p.233-241

2017

Volltextzugriff (PDF)

Discovery and Characterization of a Chemical Probe Targeting the Zinc-Finger Ubiquitin-Binding Domain of HDAC6

Journal of medicinal chemistry, 2023-08, Vol.66 (15), p.10273-10288

2023

Volltextzugriff (PDF)

Development of LM98, a Small‐Molecule TEAD Inhibitor Derived from Flufenamic Acid

ChemMedChem, 2021-10, Vol.16 (19), p.2982-3002

2021

Volltextzugriff (PDF)

Development of HC-258, a Covalent Acrylamide TEAD Inhibitor That Reduces Gene Expression and Cell Migration

ACS medicinal chemistry letters, 2023-12, Vol.14 (12), p.1746-1753

2023

Volltextzugriff (PDF)

Rational Design and Synthesis of Selective PRMT4 Inhibitors: A New Chemotype for Development of Cancer Therapeutics

ChemMedChem, 2021-04, Vol.16 (7), p.1116-1125

2021

Volltextzugriff (PDF)

Discovery and structure activity relationship of the first potent cryptosporidium FIKK kinase inhibitor

Bioorganic & medicinal chemistry, 2017-03, Vol.25 (5), p.1672-1680

2017

Volltextzugriff (PDF)

Chemical tools for the Gid4 subunit of the human E3 ligase C-terminal to LisH (CTLH) degradation complex

RSC medicinal chemistry, 2024-03, Vol.15 (3), p.166-171

2024

Volltextzugriff (PDF)

Probing the CRL4 DCAF12 interactions with MAGEA3 and CCT5 di-Glu C-terminal degrons

PNAS nexus, 2024-04, Vol.3 (4), p.pgae153

2024

Volltextzugriff (PDF)

Probing the [CRL4.sup.DCAF12] interactions with MAGEA3 and CCT5 di-Glu C-terminal degrons

PNAS nexus, 2024-04, Vol.3 (4)

2024

Volltextzugriff (PDF)

Suppression of alkene isomerisation in products from intramolecular heck reactions by addition of Tl(1) salts

Tetrahedron letters, 1991, Vol.32 (5), p.687-690

1991

Volltextzugriff (PDF)

Identification and characterization of the first fragment hits for SETDB1 Tudor domain

Bioorganic & medicinal chemistry, 2019-09, Vol.27 (17), p.3866-3878

2019

Volltextzugriff (PDF)

Identification of a C2′ - fluorinated SAH analogue

Canadian journal of chemistry, 2020-06, Vol.98 (6), p.318-321

2020

Volltextzugriff (PDF)

1 – 25 von 40

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(37)
Mit Volltextzugriff
(37)

Publikationsform

Artikel
(40)

Sprache

Englisch
(40)

Erscheinungsjahr

n.n

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Discovery of Nedd4 auto-ubiquitination inhibitors

Identification and Structure–Activity Relationship of HDAC6 Zinc-Finger Ubiquitin Binding Domain Inhibitors

Discovery and Characterization of a Highly Potent and Selective Aminopyrazoline-Based in Vivo Probe (BAY-598) for the Protein Lysine Methyltransferase SMYD2

Discovery of a Potent and Selective Coactivator Associated Arginine Methyltransferase 1 (CARM1) Inhibitor by Virtual Screening

CACHE (Critical Assessment of Computational Hit-finding Experiments): A public–private partnership benchmarking initiative to enable the development of computational methods for hit-finding

The co-crystal structure of Cbl-b and a small-molecule inhibitor reveals the mechanism of Cbl-b inhibition

Development of selective class I protein arginine methyltransferase inhibitors through fragment-based drug design approach

Discovery and Characterization of BAY-805, a Potent and Selective Inhibitor of Ubiquitin-Specific Protease USP21

Discovery of Nanomolar DCAF1 Small Molecule Ligands

Development of LM-41 and AF-2112, two flufenamic acid-derived TEAD inhibitors obtained through the replacement of the trifluoromethyl group by aryl rings

Kinetic Characterization of SARS-CoV‑2 nsp13 ATPase Activity and Discovery of Small-Molecule Inhibitors

The SUV4-20 inhibitor A-196 verifies a role for epigenetics in genomic integrity

Discovery of a First-in-Class Small-Molecule Ligand for WDR91 Using DNA-Encoded Chemical Library Selection Followed by Machine Learning

Broad analgesic activity of a novel, selective M1 agonist

Discovery and Characterization of a Chemical Probe Targeting the Zinc-Finger Ubiquitin-Binding Domain of HDAC6

Development of LM98, a Small‐Molecule TEAD Inhibitor Derived from Flufenamic Acid

Development of HC-258, a Covalent Acrylamide TEAD Inhibitor That Reduces Gene Expression and Cell Migration

Rational Design and Synthesis of Selective PRMT4 Inhibitors: A New Chemotype for Development of Cancer Therapeutics

Discovery and structure activity relationship of the first potent cryptosporidium FIKK kinase inhibitor

Chemical tools for the Gid4 subunit of the human E3 ligase C-terminal to LisH (CTLH) degradation complex

Probing the CRL4 DCAF12 interactions with MAGEA3 and CCT5 di-Glu C-terminal degrons

Probing the [CRL4.sup.DCAF12] interactions with MAGEA3 and CCT5 di-Glu C-terminal degrons

Suppression of alkene isomerisation in products from intramolecular heck reactions by addition of Tl(1) salts

Identification and characterization of the first fragment hits for SETDB1 Tudor domain

Identification of a C2′ - fluorinated SAH analogue

Suchergebnisse filtern